Following the approval, the company expects to launch the drug in the US market, and it will commence the shipments shortly.
Lansoprazole delayed-release capsules are a combination package that contains a nonsteroidal anti-inflammatory drug (NSAID) and a proton pump inhibitor (PPI).
Dr Reddy’s Lansoprazole delayed-release capsules are available in bottles of 30 & 90 counts in 15mg and 90 and 500 counts in 30mg.